Azatadine dimaleate

产品说明书

Print
Chemical Structure| 3978-86-7 同义名 : 二马来酸氮杂他定 ;Azatadine maleate; Azatadine (maleate); Zadine; Schering-Plough brand of azatadine maleate; Schering brand of azatadine maleate; Optimine; Lergocil; Key brand of azatadine maleate; Juste brand of azatadine maleate; Idulian; Idulamine; azatadine
CAS号 : 3978-86-7
货号 : A550669
分子式 : C28H30N2O8
纯度 : 98%
分子量 : 522.55
MDL号 : MFCD00242593
存储条件:

Pure form Sealed in dry,2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Azatadine Dimaleateis an histamine and cholinergic inhibitor with IC50 of 6.5 nM and 10 nM, respectively. Azatadine delays the onset of dyspnea-induced by aerosolized histamine, acetylcholine and serotonin in the conscious guinea-pig with PD50 of 0.01 mg/kg, 0.739 mg/kg and 0.86 mg/kg. Azatadine protects conscious guinea-pigs against death induced by the intravenous injection of histamine with oral PD50 of 0.009 mg/kg in guinea-pig and 0.22 mg/kg in mice[3]. Following a single oral dose of Azatadine (4 mg) in fasted volunteers, a Cmax of 3 μg/L has been measured by RIA 4.2 hours after administration. Azatadine is almost completely metabolised by hydroxylation, demethylation and formation of zwitterion isomers by oxidative ring opening. Azatadine (8.8 mg oral) in healthy volunteers results in a Csub>max of 5.9 μg/L at 5.3 hours after treatment and bioavailability of 80%[4]. Azatadine (1 mg twice daily for 14 days) is effective in relieving the histamine-mediated symptoms of seasonal allergic rhinitis[5].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.91mL

0.38mL

0.19mL

9.57mL

1.91mL

0.96mL

19.14mL

3.83mL

1.91mL

参考文献

[1]Zhang D, Hansen EB Jr, et al. Fungal biotransformation of the antihistamine azatadine by Cunninghamella elegans. Appl Environ Microbiol. 1996 Sep;62(9):3477-9.

[2]Simons FE, Simons KJ. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy. Clin Pharmacokinet. 1991 Nov;21(5):372-93.

[3]Tozzi S, Roth FE, Tabachnick II. The pharmacology of azatadine, a potential antiallergy drug. Agents Actions. 1974 Oct;4(4):264-70

[4]Simons FE, Simons KJ. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy. Clin Pharmacokinet. 1991 Nov;21(5):372-93

[5]Katelaris C. Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis. Asian Pac J Allergy Immunol. 1990 Dec;8(2):103-7